{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:17:58Z","timestamp":1778656678036,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Genetics & Development"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.gde.2004.12.006","type":"journal-article","created":{"date-parts":[[2004,12,22]],"date-time":"2004-12-22T10:14:56Z","timestamp":1103710496000},"page":"49-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["OVCA1: tumor suppressor gene"],"prefix":"10.1016","volume":"15","author":[{"given":"Chun-Ming","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard R","family":"Behringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gde.2004.12.006_bib1","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1086\/378522","article-title":"Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions","volume":"73","author":"Miller","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2004.12.006_bib2","first-page":"6716","article-title":"Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas","volume":"52","author":"Saxena","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.gde.2004.12.006_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ijc.2910540115","article-title":"Allelic loss on chromosome 17 in human ovarian cancer","volume":"54","author":"Phillips","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gde.2004.12.006_bib4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0165-4608(94)90458-8","article-title":"Evidence for a second tumor suppressor gene on 17p linked to high S-phase index in primary human breast carcinomas","volume":"76","author":"Merlo","year":"1994","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.gde.2004.12.006_bib5","first-page":"606","article-title":"Allelic deletion on chromosome 17p13.3 in early ovarian cancer","volume":"56","author":"Phillips","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.gde.2004.12.006_bib6","first-page":"1997","article-title":"Identification of two candidate tumor suppressor genes on chromosome 17p13.3","volume":"56","author":"Schultz","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.gde.2004.12.006_bib7","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1038\/sj.onc.1202128","article-title":"Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers","volume":"17","author":"Konishi","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.gde.2004.12.006_bib8","first-page":"1004","article-title":"Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters","volume":"58","author":"Phelan","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.gde.2004.12.006_bib9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sj.bjc.6690427","article-title":"Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene","volume":"80","author":"Liscia","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.gde.2004.12.006_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0165-4608(01)00450-2","article-title":"Allelic imbalance and fine mapping of the 17p13.3 subregion in sporadic breast carcinomas","volume":"129","author":"Hoff","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.gde.2004.12.006_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3835(96)04169-9","article-title":"A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3","volume":"102","author":"Phillips","year":"1996","journal-title":"Cancer Lett"},{"key":"10.1016\/j.gde.2004.12.006_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0378-1119(93)90528-B","article-title":"Diphthamide synthesis in Saccharomyces cerevisiae: structure of the DPH2 gene","volume":"132","author":"Mattheakis","year":"1993","journal-title":"Gene"},{"key":"10.1016\/j.gde.2004.12.006_bib13","doi-asserted-by":"crossref","first-page":"10710","DOI":"10.1016\/S0021-9258(19)70365-2","article-title":"ADP-ribosylation of elongation factor 2 by diphtheria toxin. NMR spectra and proposed structures of ribosyl-diphthamide and its hydrolysis products","volume":"255","author":"Van Ness","year":"1980","journal-title":"J Biol Chem"},{"key":"10.1016\/j.gde.2004.12.006_bib14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/geno.1998.5420","article-title":"Cloning and localization of a human diphthamide biosynthesis-like protein-2 gene, DPH2L2","volume":"52","author":"Schultz","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.gde.2004.12.006_bib15","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1073\/pnas.061034498","article-title":"A comprehensive two-hybrid analysis to explore the yeast protein interactome","volume":"98","author":"Ito","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gde.2004.12.006_bib16","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1126\/science.1090289","article-title":"A protein interaction map of Drosophila melanogaster","volume":"302","author":"Giot","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.gde.2004.12.006_bib17","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1006\/bbrc.2001.5488","article-title":"Cloning, structure, and expression of the mouse Ovca1 gene","volume":"286","author":"Chen","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.gde.2004.12.006_bib18_1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1101\/gad.1162204","article-title":"Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis","volume":"18","author":"Chen","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.gde.2004.12.006_bib19","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1093\/emboj\/17.23.6783","article-title":"Tumor suppressor gene mutations in humans and mice: parallels and contrasts","volume":"17","author":"Hooper","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.gde.2004.12.006_bib20","series-title":"The Genetic Basis of Human Cancer","first-page":"387","article-title":"Li-Fraumeni syndrome","author":"Malkin","year":"2002"},{"key":"10.1016\/j.gde.2004.12.006_bib21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/90108","article-title":"Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis","volume":"28","author":"Xu","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2004.12.006_bib22","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1128\/MCB.18.7.4385","article-title":"Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm\u2212\/\u2212 mice","volume":"18","author":"Xu","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.gde.2004.12.006_bib23","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1128\/MCB.20.11.3772-3780.2000","article-title":"Analysis of ku80-mutant mice and cells with deficient levels of p53","volume":"20","author":"Lim","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.gde.2004.12.006_bib24","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0002-9440(10)64853-5","article-title":"Development of spontaneous mammary tumors in BALB\/c p53 heterozygous mice. A model for Li-Fraumeni syndrome","volume":"157","author":"Kuperwasser","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.gde.2004.12.006_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/humu.10181","article-title":"TP53 and ovarian cancer","volume":"21","author":"Schuijer","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.gde.2004.12.006_bib26_1","doi-asserted-by":"crossref","first-page":"7722","DOI":"10.1038\/sj.onc.1208037","article-title":"Tumor formation in p53 mutant ovaries transplanted into wild-type female hosts","volume":"23","author":"Chen","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.gde.2004.12.006_bib27_1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng1077","article-title":"Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors","volume":"33","author":"Chen","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2004.12.006_bib28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0006-291X(02)02751-1","article-title":"Identification of genes induced by BRCA1 in breast cancer cells","volume":"299","author":"Atalay","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.gde.2004.12.006_bib29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nm0695-570","article-title":"p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3","volume":"1","author":"Wales","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.gde.2004.12.006_bib30_1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.molcel.2003.08.003","article-title":"Retroviral insertional mutagenesis identifies a small protein required for synthesis of diphthamide, the target of bacterial ADP-ribosylation toxins","volume":"12","author":"Liu","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.gde.2004.12.006_bib31","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/emboj\/20.8.1993","article-title":"Saccharomyces cerevisiae Elongator mutations confer resistance to the Kluyveromyces lactis zymocin","volume":"20","author":"Frohloff","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.gde.2004.12.006_bib32","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1365-2958.2002.02928.x","article-title":"KTI11 and KTI13, Saccharomyces cerevisiae genes controlling sensitivity to G1 arrest induced by Kluyveromyces lactis zymocin","volume":"44","author":"Fichtner","year":"2002","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.gde.2004.12.006_bib33_1","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1046\/j.1365-2958.2003.03632.x","article-title":"Elongator's toxin-target (TOT) function is nuclear localization sequence dependent and suppressed by post-translational modification","volume":"49","author":"Fichtner","year":"2003","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.gde.2004.12.006_bib34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng904","article-title":"Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer","volume":"31","author":"Anand","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2004.12.006_bib35","doi-asserted-by":"crossref","first-page":"9487","DOI":"10.1128\/MCB.24.21.9487-9497.2004","article-title":"Identification of the proteins required for biosynthesis of diphthamide, the target of bacterial ADP-ribosylating toxins on translation elongation factor 2","volume":"24","author":"Liu","year":"2004","journal-title":"Mol Cell Biol"}],"container-title":["Current Opinion in Genetics & Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X04001923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X04001923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:27:53Z","timestamp":1760700473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959437X04001923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0959437X04001923"],"URL":"https:\/\/doi.org\/10.1016\/j.gde.2004.12.006","relation":{},"ISSN":["0959-437X"],"issn-type":[{"value":"0959-437X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OVCA1: tumor suppressor gene","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Genetics & Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gde.2004.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}